These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23899444)

  • 1. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy.
    Chu KS; Schorzman AN; Finniss MC; Bowerman CJ; Peng L; Luft JC; Madden AJ; Wang AZ; Zamboni WC; DeSimone JM
    Biomaterials; 2013 Nov; 34(33):8424-9. PubMed ID: 23899444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.
    Sambade M; Deal A; Schorzman A; Luft JC; Bowerman C; Chu K; Karginova O; Swearingen AV; Zamboni W; DeSimone J; Anders CK
    Nanomedicine (Lond); 2016 Aug; 11(15):1947-55. PubMed ID: 27456556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
    Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
    Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
    Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR
    Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity.
    Sethi M; Sukumar R; Karve S; Werner ME; Wang EC; Moore DT; Kowalczyk SR; Zhang L; Wang AZ
    Nanoscale; 2014 Feb; 6(4):2321-2327. PubMed ID: 24418914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.
    Hrkach J; Von Hoff D; Mukkaram Ali M; Andrianova E; Auer J; Campbell T; De Witt D; Figa M; Figueiredo M; Horhota A; Low S; McDonnell K; Peeke E; Retnarajan B; Sabnis A; Schnipper E; Song JJ; Song YH; Summa J; Tompsett D; Troiano G; Van Geen Hoven T; Wright J; LoRusso P; Kantoff PW; Bander NH; Sweeney C; Farokhzad OC; Langer R; Zale S
    Sci Transl Med; 2012 Apr; 4(128):128ra39. PubMed ID: 22491949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
    Werner ME; Copp JA; Karve S; Cummings ND; Sukumar R; Li C; Napier ME; Chen RC; Cox AD; Wang AZ
    ACS Nano; 2011 Nov; 5(11):8990-8. PubMed ID: 22011071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
    Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
    Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation.
    Gan CW; Chien S; Feng SS
    Curr Pharm Des; 2010 Jul; 16(21):2308-20. PubMed ID: 20618152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.
    Enlow EM; Luft JC; Napier ME; DeSimone JM
    Nano Lett; 2011 Feb; 11(2):808-13. PubMed ID: 21265552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer.
    Liang Z; Yang N; Jiang Y; Hou C; Zheng J; Shi J; Zhang R; Li D; Liu Y; Zuo P
    Int J Pharm; 2015 Oct; 494(1):337-45. PubMed ID: 26299762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model.
    Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS
    Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.
    Chu KS; Hasan W; Rawal S; Walsh MD; Enlow EM; Luft JC; Bridges AS; Kuijer JL; Napier ME; Zamboni WC; DeSimone JM
    Nanomedicine; 2013 Jul; 9(5):686-93. PubMed ID: 23219874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.